Skip to content

MRC/LMB talk: What next in your career 2016?

The MRC/LMB and CamAWiSE joint annual ‘What next in your career?’ talk will take place on Thursday 30th June, 12-1pm in the Max Perutz Lecture Theatre.

The speakers are:

Dr Hayley Sharpe, Principal Investigator at the CIMR, University of Cambridge
Dr Burcu Babaoglan Fiehler, Clinical Trials Coordinator, Cambridge University Hospitals NHS Foundation Trust
Dr Ryan Fiehler, Senior Scientist at F-star Biotechnology Ltd.

The speakers (biographies are below) will lead a short panel discussion after their talks followed by a buffet lunch which will provide a great opportunity for networking and gaining advice about making that next step!

All are welcome and the event is free to attend, but please register at eventbrite: http://mrc.io/1sEVHgB
When: Thursday, 30 June 2016 from 12:00 to 14:00 (BST) – Add to Calendar
Where: MRC Laboratory of Molecular Biology – Francis Crick Avenue, Cambridge, CB2 0QH

More about the speakers:

Dr Hayley Sharpe, Principal Investigator at the CIMR, University of Cambridge

Hayley completed her PhD studies at the LMB in 2010 and in 2011 joined Genentech Inc., South San Francisco as a postdoc. In 2016, she was awarded a Wellcome Trust/Royal Society Sir Henry Dale Fellowship and established her own research group. Her lab investigates how cells communicate through tyrosine phosphatase signalling using proteomics, genetics and cell biology approaches.

Dr Burcu Babaoglan Fiehler, Clinical Trials Coordinator in Cambridge Clinical Trials Centre (CCTU-CT)

Burcu carried out her PhD studies at Washington University in St Louis, MO, USA, finishing in 2008. In 2009 she joined Sarah Bray’s Lab in the Cambridge University PDN department as a postdoc to continue her work on Notch signalling. In 2013, she finished her postdoc and steered away from basic science towards clinical research to work on cancer trials in CCTU. She currently runs a multi-centre trial called SIEGE to investigate two different schedules of nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic ductal adenocarcinoma.

Dr Ryan Fiehler, Senior Scientist at F-star Biotechnology Ltd

Ryan completed his studies at Washington University in St. Louis in 2007 and joined Fiona Watt’s lab at the CRUK Cambridge Institute in 2009 as a post-doc investigating skin homeostasis and cancer. This research was funded by the NIH under the Ruth L Kirchstein grant awarded in 2010. In 2013 Ryan joined F-star Biotechnology Ltd, engineering bi-specific antibodies. He is currently the lead scientist on a project targeting an immune checkpoint regulator.

Burcu and Ryan will give an insight into their successful two-career partnership.

 

 

%d bloggers like this: